VRP.L Share News (VRP)
VRP Share
VRP Share
VRP Share
VRP Share
VRP
VRP Share
VRP Broker
VRP Directors
VRP Financial
VRP
VRP Short
VRPThu, 29th Oct 2020 19:09
Verona Pharma PLC - clinical-stage biopharmaceutical company - Pretax loss in third quarter ended September 30 widens to USD22.2 million from USD15.7 million a year earlier. For nine-months to September, loss stretches to USD47.1 million from USD38.7 million.
Current stock price: 51.00 pence
Year-to-date change: down 18%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
The chairman of Verona Pharma increased his stake in the company following Monday's news that the biotechnology firm has dosed its first group of volunteers in its asthma trial. David Ebsworth showed confidence in the future of the business by purchasing 803,107 shares for 1.35p each, spending a tot
Read more